ArticleInternational journal of clinical pharmacy2026
Scoping review of apixaban and rivaroxaban dosing for atrial fibrillation and venous thromboembolism in advanced chronic kidney disease.
Sophie Gillis et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.